New Melanoma clinical trials: 262 posted since Nov 2024

Name: New Melanoma clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Melanoma clinical trials: 262 rows for $13.10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 11 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/melanoma, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated October 23, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

262 clinical studies in melanoma were first posted on ClinicalTrials.gov from November 12, 2024 to October 23, 2026; 83 have an industry sponsor and 209 are recruiting or about to. The newest, NCT07891286, was posted on October 23, 2026: Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young... (National Cancer Institute (NCI)).

The request: Every new Melanoma clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

262New trials
83Industry sponsored
209Recruiting or not yet
October 23, 2026Latest posted

Newest trials

The newest 100 of 262, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
October 23, 2026	NCT07891286	Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults	National Cancer Institute (NCI)	Phase 2	Not yet recruiting	LGCMN, Large and Giant Congenital Melanocytic Nevi, NF1, Solid Tumor, Pediatric Tumors, Neurocutaneous Melanocytosis...	15	United States	clinicaltrials.gov
October 22, 2026	NCT07890415	Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis	Memorial Sloan Kettering Cancer Center	Phase 3	Recruiting	Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin, Melanoma in Situ, Carcinoma in Situ of...	14,000	United States	clinicaltrials.gov
October 20, 2026	NCT07883954	Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test	Mitra Bio	Observational	Recruiting	Melanoma	2,000	Belgium, Germany, Spain, United Kingdom	clinicaltrials.gov
October 20, 2026	NCT07883759	Neoadjuvant Pembrolizumab in Patients With High Risk, Stage IIB/IIC Cutaneous Melanoma: a Single Arm Proof of Concept Phase IIA Study.	Centre Hospitalier Universitaire de Besancon	Phase 2	Not yet recruiting	Stage IIB Melanoma, Stage IIC Melanoma	19	France	clinicaltrials.gov
October 13, 2026	NCT07870265	Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System	Masaryk Memorial Cancer Institute	Not applicable	Recruiting	Unresectable Metastatic Melanoma	17	Czechia	clinicaltrials.gov
October 9, 2026	NCT07869381	Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma	University of Nebraska	Not applicable	Not yet recruiting	Cutaneous Melanoma, Stage II, Cutaneous Melanoma, Acral Melanoma	282	United States	clinicaltrials.gov
October 9, 2026	NCT07869186	Dermatological Effects and Quality of Life in Oncology Patients	European Institute of Oncology	Not applicable	Not yet recruiting	Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer	300	Italy	clinicaltrials.gov
October 7, 2026	NCT07862530	Neoadjuvant RP2 + Nivolumab in Patients With Melanoma	Yana Najjar	Phase 2	Not yet recruiting	MelanomaCutaneous Melanoma Resectable, Melanoma	34	United States	clinicaltrials.gov
October 6, 2026	NCT07861022	Biomechanical Characterization of Skin Properties Using Impact Based-Analysis Method (IBAM)	Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris	Observational	Not yet recruiting	Melanoma (Skin Cancer), Skin Carcinoma	10		clinicaltrials.gov
October 5, 2026	NCT07857616	SI-B036-ST-101 in Advanced/Metastatic Solid Tumors	SystImmune Inc.	Phase 1	Recruiting	Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, Metastatic Solid Cancers, Non...	424	United States	clinicaltrials.gov
October 2, 2026	NCT07854522	A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma	Peking University Cancer Hospital & Institute	Phase 4	Not yet recruiting	Melanoma, Acral Melanoma	76		clinicaltrials.gov
September 29, 2026	NCT07848243	Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes	Peking University Cancer Hospital & Institute	Phase 2	Recruiting	Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal Cancers	50	China	clinicaltrials.gov
September 29, 2026	NCT07847359	Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib...	Sun Yat-sen University	Phase 2	Recruiting	Melanoma (Skin) Stage IV	28	China	clinicaltrials.gov
September 25, 2026	NCT07841925	A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors	Sichuan Baili Pharmaceutical Co., Ltd.	Phase 1/2	Recruiting	Melanoma, Solid Tumors	30	China	clinicaltrials.gov
September 24, 2026	NCT07838974	Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or Older	University of Southern California	Phase 1	Not yet recruiting	Melanoma	40	United States	clinicaltrials.gov
September 23, 2026	NCT07836712	Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced...	University of Southern California	Phase 2	Not yet recruiting	Advanced Hepatocellular Carcinoma, Advanced Melanoma, Locally Advanced Melanoma, Metastatic Melanoma, Stage III...	46	United States	clinicaltrials.gov
September 21, 2026	NCT07831083	Skin Cancer Among Outdoor Workers	Assuta Medical Center	Observational	Completed	Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin, Squamous Cell Cancer of Head and Neck (SCCHN), Work Injury, Sun...	10,000	Israel	clinicaltrials.gov
September 21, 2026	NCT07830225	A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.	Rutgers, The State University of New Jersey	Not applicable	Recruiting	Melanoma (Skin Cancer)	35	United States	clinicaltrials.gov
September 15, 2026	NCT07820033	Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial	University Health Network, Toronto	Phase 2	Not yet recruiting	Advanced Cancer, Stage IV Solid Tumor Cancer, Stage IV Sarcoma of Bone, Stage IV Lymphoma, Stage IV Melanoma, Endocrine...	46	Canada	clinicaltrials.gov
September 14, 2026	NCT07817901	Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With...	Yonsei University	Phase 1/2	Not yet recruiting	Unresectable or Metastatic Melanoma	46		clinicaltrials.gov
September 11, 2026	NCT07815873	Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers	European Institute of Oncology	Not applicable	Not yet recruiting	Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer	360	Italy	clinicaltrials.gov
September 11, 2026	NCT07815574	iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma	Scancell Ltd	Phase 3	Not yet recruiting	Melanoma (Skin Cancer), Advanced Melanoma, Metastatic Melanoma, Skin Cancer	550	United Kingdom, United States	clinicaltrials.gov
September 8, 2026	NCT07808164	ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort	Tam Anh Research Institute	Observational	Recruiting	HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial...	162	Vietnam	clinicaltrials.gov
September 8, 2026	NCT07807878	Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma	Assistance Publique Hopitaux De Marseille	Phase 2	Not yet recruiting	Cutaneous Melanoma	28		clinicaltrials.gov
September 1, 2026	NCT07796594	Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer	Amsterdam UMC, location VUmc	Not applicable	Active not recruiting	Melanoma, Pancreas Cancer	180	Netherlands	clinicaltrials.gov
August 31, 2026	NCT07794501	Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma	European Institute of Oncology	Observational	Not yet recruiting	Metastatic Melanoma	200		clinicaltrials.gov
August 26, 2026	NCT07788729	Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons	University of Regensburg	Not applicable	Recruiting	Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer, Malignant Melanoma	384	Germany	clinicaltrials.gov
August 12, 2026	NCT07761871	Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy	Institute of Oncology Ljubljana	Not applicable	Not yet recruiting	Melanoma	40	Slovenia	clinicaltrials.gov
August 12, 2026	NCT07760012	68Ga-SorB PET/CT Imaging in Patients With Solid Tumors	Peking University Third Hospital	Not applicable	Recruiting	Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer...	50	China	clinicaltrials.gov
August 11, 2026	NCT07757386	MelaMEd Online Training for General Practitioners to Improve Melanoma Detection and Management	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Not applicable	Completed	Cutaneous Melanoma	1,531	Italy	clinicaltrials.gov
August 6, 2026	NCT07751042	Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab	Strand Therapeutics Inc.	Phase 1/2	Recruiting	Advanced Solid Tumor	220	Australia, United States	clinicaltrials.gov
August 6, 2026	NCT07750067	Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma	Sun Yat-sen University	Phase 2	Recruiting	Melanoma Metastatic, NRAS Mutation	37	China	clinicaltrials.gov
August 6, 2026	NCT07749586	A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors	Arvinas Inc.	Phase 1/2	Recruiting	Advanced Solid Tumor	499	United States	clinicaltrials.gov
August 3, 2026	NCT07740941	NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma	UNC Lineberger Comprehensive Cancer Center	Phase 2	Recruiting	Melanoma (Skin Cancer), Melanoma Stage Stage IIIB, Melanoma Stage M1, Melanoma Stage IV	55	United States	clinicaltrials.gov
July 31, 2026	NCT07740642	A Comparative Usability Study of Two Total Body Skin Imaging Systems	University Hospital, Basel, Switzerland	Not applicable	Not yet recruiting	Melanoma (Skin Cancer)	60	Switzerland	clinicaltrials.gov
July 22, 2026	NCT07720726	Impact of Dysport on PMFF Donor Scar	Vanderbilt University Medical Center	Phase 4	Not yet recruiting	Skin Cancer Excision Site, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma	50	United States	clinicaltrials.gov
July 21, 2026	NCT07718243	Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC	Institute of Cancer Research, United Kingdom	Phase 1/2	Recruiting	Melanoma (Skin Cancer), Non Small Cell Lung Cancer, Solid Tumor in Advanced Stage	62	United Kingdom	clinicaltrials.gov
July 15, 2026	NCT07704918	Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma	University of Colorado, Denver	Not applicable	Recruiting	Melanoma	40	United States	clinicaltrials.gov
July 13, 2026	NCT07700121	PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma	Abramson Cancer Center at Penn Medicine	Early phase 1	Not yet recruiting	Unresectable or Metastatic Melanoma	10	United States	clinicaltrials.gov
July 10, 2026	NCT07696715	Timing of Immunotherapy in Melanoma	Radboud University Medical Center	Not applicable	Recruiting	Melanoma	170	Netherlands	clinicaltrials.gov
July 10, 2026	NCT07694414	Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events	Inge Marie Svane	Phase 1	Recruiting	Immune-Related Adverse Events	25	Denmark	clinicaltrials.gov
July 8, 2026	NCT07691255	MELanoma Brain Metastasis Treated With CYberknife	European Institute of Oncology	Observational	Recruiting	Melanoma (Skin Cancer)	50	Italy	clinicaltrials.gov
July 8, 2026	NCT07689812	A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI)...	Natera, Inc.	Not applicable	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Carcinoma)...	920		clinicaltrials.gov
July 7, 2026	NCT07686835	Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.	Radboud University Medical Center	Phase 2	Recruiting	Melanoma (Skin) Stage IV, Melanoma (Skin Cancer), Melanoma Metastatic, Melanoma Advanced, Melanoma	70	Netherlands	clinicaltrials.gov
July 2, 2026	NCT07680699	NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma	AC Camargo Cancer Center	Observational	Recruiting	Cutaneous Melanoma	250	Brazil	clinicaltrials.gov
July 2, 2026	NCT07680452	Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition	Charite University, Berlin, Germany	Not applicable	Recruiting	Melanoma (Skin Cancer)	60	Germany	clinicaltrials.gov
June 26, 2026	NCT07671495	Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin	MIPO Clinic	Phase 2	Completed	Melanoma Stage I, Melanoma Stage III, Melanoma Stage II, Skin Melanoma	278		clinicaltrials.gov
June 26, 2026	NCT07670403	Digital Phenotyping of Psychological Distress in Skin Cancer Patients	West China Hospital	Observational	Withdrawn	Skin Cancer, Melanoma (Skin Cancer), Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Basal Cell Carcinoma of Skin	0	China	clinicaltrials.gov
June 22, 2026	NCT07661966	Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade	Weill Medical College of Cornell University	Not applicable	Recruiting	Melanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer)	12	United States	clinicaltrials.gov
June 22, 2026	NCT07660666	Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for...	OHSU Knight Cancer Institute	Not applicable	Not yet recruiting	Melanoma	50	United States	clinicaltrials.gov
June 17, 2026	NCT07653087	Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma	University of Virginia	Not applicable	Not yet recruiting	Sentinel Lymph Node Biopsy (SLNB), Melanoma (Skin Cancer)	66	United States	clinicaltrials.gov
June 16, 2026	NCT07651618	A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant...	East Metropolitan Health Service, Australia	Phase 2	Not yet recruiting	Melanoma (Skin Cancer), Melanoma Metastatic	10	Australia	clinicaltrials.gov
June 16, 2026	NCT07651020	The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Observational	Completed	Pancreatic Cancer, Breast Cancer, Lung Cancer, Sarcoma, Head and Neck Cancers, Glioblastoma, Colorectal Cancer...	1	China	clinicaltrials.gov
June 16, 2026	NCT07649681	Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention	Wuerzburg University Hospital	Not applicable	Recruiting	Multiple Myeloma (MM), GI Cancer, Taste Disorder, Melanoma (Skin Cancer), Urogenital Cancers	198	Germany	clinicaltrials.gov
June 16, 2026	NCT07649252	A Study of Patient Characteristics and Treatment Patterns in Real-world Melanoma Patients Treated With Dabrafenib and Trametinib or...	Novartis Pharmaceuticals	Observational	Completed	Melanoma	82	Japan	clinicaltrials.gov
June 12, 2026	NCT07645742	Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors	West Virginia University	Not applicable	Not yet recruiting	Cancer (Advanced Stage)	90		clinicaltrials.gov
June 12, 2026	NCT07644897	Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma	Sun Yat-sen University	Phase 2	Recruiting	Melanoma, Immune-related Adverse Event, Immune Checkpoint Inhibitor	55	China	clinicaltrials.gov
June 9, 2026	NCT07635732	Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy	Medical University of Graz	Observational	Recruiting	Melanoma Stage IV	50	Austria	clinicaltrials.gov
June 5, 2026	NCT07628894	Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy	City of Hope Medical Center	Phase 1	Not yet recruiting	Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC...	8	United States	clinicaltrials.gov
June 5, 2026	NCT07628634	Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors	University of California, Irvine	Early phase 1	Recruiting	Adenocarcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Ductal Carcinoma...	25	United States	clinicaltrials.gov
June 4, 2026	NCT07627698	Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma	Beijing Biotech	Phase 1/2	Recruiting	Unresectable Melanoma, Metastatic Cutaneous Melanoma, Metastatic Uveal Melanoma	36	China	clinicaltrials.gov
June 2, 2026	NCT07621614	A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information	Children's Oncology Group	Phase 2	Recruiting	Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous...	51	United States	clinicaltrials.gov
June 2, 2026	NCT07619898	PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to...	Therakos LLC	Phase 2	Not yet recruiting	Colitis, Hepatitis, Melanoma (Skin Cancer)	112		clinicaltrials.gov
May 29, 2026	NCT07615881	Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma	Amsterdam UMC, location VUmc	Phase 1/2	Not yet recruiting	Melanoma (Skin Cancer)	18		clinicaltrials.gov
May 20, 2026	NCT07600476	A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid...	Kupando GmbH	Phase 1	Recruiting	Cutaneous Melanoma, Mucosal Melanoma, Cutaneous Squamous Cell Carcinoma (CSCC), Merkel Cell Carcinoma of Skin, Basal...	21	Germany	clinicaltrials.gov
May 14, 2026	NCT07586904	Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.	Xijing Hospital	Early phase 1	Recruiting	Melanoma (Skin Cancer)	10	China	clinicaltrials.gov
May 14, 2026	NCT07586891	Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With...	Xijing Hospital	Not applicable	Recruiting	Melanoma (Skin Cancer)	80	China	clinicaltrials.gov
May 13, 2026	NCT07584291	Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma	Xijing Hospital	Observational	Recruiting	Melanoma (Skin Cancer)	200	China	clinicaltrials.gov
May 12, 2026	NCT07581509	Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma	Biocon Biologics UK PLC	Phase 1	Recruiting	Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)	138	Brazil	clinicaltrials.gov
May 8, 2026	NCT07576725	Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial	Fred Hutchinson Cancer Center	Phase 2	Not yet recruiting	Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical...	50	Uganda	clinicaltrials.gov
May 7, 2026	NCT07574047	MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.	Swiss Cancer Institute	Phase 2	Recruiting	Melanoma, Advanced Melanoma	108	Switzerland	clinicaltrials.gov
May 4, 2026	NCT07565285	The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma	Primmune Therapeutics, Inc.	Phase 2	Recruiting	Melanoma Stage III	48	Australia	clinicaltrials.gov
May 4, 2026	NCT07564570	Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma	Universitätsklinikum Hamburg-Eppendorf	Not applicable	Recruiting	Metastatic Melanoma	40	Germany	clinicaltrials.gov
April 29, 2026	NCT07556380	Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions	Northwestern University	Not applicable	Active not recruiting	Melanoma (Skin Cancer)	150	United States	clinicaltrials.gov
April 29, 2026	NCT07555210	Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy	Jessica Mezzanotte Sharpe	Not applicable	Recruiting	Breast Cancer (Triple Negative Breast Cancer (TNBC)), Renal Cell Carcinoma (Kidney Cancer), Melanoma (Skin Cancer)...	25	United States	clinicaltrials.gov
April 27, 2026	NCT07552597	Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II	Vastra Gotaland Region	Phase 3	Not yet recruiting	Melanoma (Skin Cancer)	254		clinicaltrials.gov
April 27, 2026	NCT07552467	Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors...	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Observational	Recruiting	Pancreatic Cancer, Breast Cancer, Lung Cancer, Sarcoma, Head and Neck Tumors, Glioblastoma, Colorectal Cancer, Melanoma	26	China	clinicaltrials.gov
April 15, 2026	NCT07531121	ctDNA for Risk Stratification in Melanoma	Herlev and Gentofte Hospital	Observational	Active not recruiting	Melanoma (Skin Cancer)	296	Denmark	clinicaltrials.gov
April 15, 2026	NCT07530887	NO Re-excision MelanomA - NORMA 2	Marieke Goodijk	Phase 3	Recruiting	Melanoma (Skin Cancer)	1,749	Netherlands	clinicaltrials.gov
April 14, 2026	NCT07529080	Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer...	University of Michigan Rogel Cancer Center	Not applicable	Not yet recruiting	Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm, Melanoma, Thyroid Gland Follicular Carcinoma...	142	United States	clinicaltrials.gov
April 14, 2026	NCT07527325	Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma	University of California, Irvine	Phase 2	Not yet recruiting	Melanoma (Skin)	35	United States	clinicaltrials.gov
April 13, 2026	NCT07524114	Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)	University Health Network, Toronto	Observational	Recruiting	Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer, Genitourinary Cancer, Pancreatobiliary Cancer...	7,000	Canada	clinicaltrials.gov
April 9, 2026	NCT07519655	Phase 1 Study of PF-08046033 in Advanced Solid Tumors	Pfizer	Phase 1	Recruiting	Non-Small-Cell Lung, Esophageal Cancer, Cutaneous Melanoma	250	France, Netherlands, Puerto Rico, South Korea, Spain, United States	clinicaltrials.gov
April 8, 2026	NCT07518043	A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors	Shanghai Henlius Biotech	Phase 1	Recruiting	Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)	174	China	clinicaltrials.gov
April 8, 2026	NCT07517653	Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Melanoma	70		clinicaltrials.gov
April 6, 2026	NCT07511036	PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically...	M.D. Anderson Cancer Center	Phase 2	Not yet recruiting	Melanoma	20	United States	clinicaltrials.gov
April 1, 2026	NCT07504796	ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab	NYU Langone Health	Phase 2	Recruiting	Metastatic Melanoma, Advanced Melanoma	90	United States	clinicaltrials.gov
March 30, 2026	NCT07501104	Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Melanoma (Skin Cancer)	30		clinicaltrials.gov
March 25, 2026	NCT07492680	A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic...	Bristol-Myers Squibb	Phase 2	Recruiting	Solid Tumors	254	Belgium, Canada, China, France, Germany, Hong Kong, Ireland, Italy, Japan...	clinicaltrials.gov
March 25, 2026	NCT07492121	Screening for Brain Metastases	University of Zurich	Phase 2	Not yet recruiting	Lung Cancer Stage IV, Melanoma Stage IV, Breast Cancer Metastatic	180	Switzerland	clinicaltrials.gov
March 17, 2026	NCT07476326	Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma	Biocon Biologics UK PLC	Phase 1	Recruiting	Melanoma	120	Brazil, Chile, Georgia, Moldova, Romania, Serbia, South Africa, Spain, Turkey...	clinicaltrials.gov
March 16, 2026	NCT07475572	Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma	Alvotech Swiss AG	Phase 1	Recruiting	Melanoma	120	Ukraine	clinicaltrials.gov
March 13, 2026	NCT07469709	A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks	Fondazione del Piemonte per l'Oncologia	Observational	Recruiting	Breast Cancer, Colo-rectal Cancer, Ovarian Cancer, Melanoma (Skin Cancer), Non-Small Cell Lung Cancer (MeSH Term...	850	Italy	clinicaltrials.gov
March 9, 2026	NCT07459543	A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic...	Bristol-Myers Squibb	Phase 4	Not yet recruiting	Unresectable Melanoma, Metastatic Melanoma	40	India	clinicaltrials.gov
March 4, 2026	NCT07449754	Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma	Hanmi Pharmaceutical Company Limited	Phase 2	Recruiting	Advanced or Metastatic Melanoma	45	South Korea	clinicaltrials.gov
March 4, 2026	NCT07448831	A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.	Universitair Ziekenhuis Brussel	Phase 2	Recruiting	Melanoma (Skin Cancer)	49	Belgium	clinicaltrials.gov
March 3, 2026	NCT07444606	Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases	M.D. Anderson Cancer Center	Phase 1	Recruiting	Melanoma	50	United States	clinicaltrials.gov
March 2, 2026	NCT07442292	PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor	Peking University Cancer Hospital & Institute	Observational	Not yet recruiting	Lung Cancer (NSCLC), Lung Cancer (SCLC), Melanoma (Skin Cancer), Melanoma Metastatic, PD-L1, PET / CT	40		clinicaltrials.gov
February 27, 2026	NCT07437300	Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.	University Hospital, Grenoble	Observational	Not yet recruiting	Melanoma	60		clinicaltrials.gov
February 27, 2026	NCT07436390	IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma	Institute of Oncology Ljubljana	Not applicable	Completed	Metastatic Melanoma, Malignant Melanoma, Skin Cancer	132	Slovenia	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Institute of Oncology Ljubljana	9	August 12, 2026
European Institute of Oncology	4	October 9, 2026
Xijing Hospital	4	May 14, 2026
Vastra Gotaland Region	4	April 27, 2026
Pfizer	4	April 9, 2026
National Cancer Institute (NCI)	3	October 23, 2026
Peking University Cancer Hospital & Institute	3	October 2, 2026
Sun Yat-sen University	3	September 29, 2026
University Health Network, Toronto	3	September 15, 2026
University of California, Irvine	3	June 5, 2026
M.D. Anderson Cancer Center	3	April 6, 2026
Bristol-Myers Squibb	3	March 25, 2026
AI Labs Group S.L	3	February 24, 2026
Grupo Español Multidisciplinar de Melanoma	3	July 10, 2025
Yana Najjar	2	October 7, 2026
University of Southern California	2	September 24, 2026
Amsterdam UMC, location VUmc	2	September 1, 2026
Arvinas Inc.	2	August 6, 2026
Radboud University Medical Center	2	July 10, 2026
Natera, Inc.	2	July 8, 2026

By phase

Phase	New trials	Latest
Observational	58	October 20, 2026
Phase 2	57	October 23, 2026
Not applicable	55	October 13, 2026
Phase 1	39	October 5, 2026
Phase 1/2	33	September 25, 2026
Phase 3	8	October 22, 2026
Phase 4	6	October 2, 2026
Early phase 1	5	July 13, 2026
Phase 2/3	1	December 30, 2025

By country

Country	New trials	Latest
United States	91	October 23, 2026
China	38	September 29, 2026
Italy	23	October 9, 2026
Australia	21	August 6, 2026
Spain	19	October 20, 2026
Germany	18	October 20, 2026
France	17	October 20, 2026
United Kingdom	14	October 20, 2026
Netherlands	11	September 1, 2026
Canada	10	September 15, 2026
Slovenia	10	August 12, 2026
Belgium	7	October 20, 2026
Israel	6	September 21, 2026
Switzerland	5	July 31, 2026
Denmark	5	July 10, 2026
Brazil	5	July 2, 2026
Turkey (Türkiye)	5	March 17, 2026
South Korea	4	April 9, 2026
Sweden	4	January 16, 2026
Czechia	3	October 13, 2026
Japan	3	June 16, 2026
Puerto Rico	3	April 9, 2026
Georgia	3	March 17, 2026
Ukraine	3	March 17, 2026
Greece	3	October 28, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.